PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-4218

  1. 585 Posts.
    lightbulb Created with Sketch. 64
    What pushback are you referring to?
    All I can see is the (long and slow) process of the FDA and no pushback from TGA yet?

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.